-+ 0.00%
-+ 0.00%
-+ 0.00%

UBS Maintains Buy on Cardinal Health, Raises Price Target to $295

Benzinga·10/16/2026 17:40:17
语音播报
UBS analyst Kevin Caliendo maintains Cardinal Health (NYSE:CAH) with a Buy and raises the price target from $280 to $295.